Early-phase vs. late-phase clinical trials in gynecologic oncology: Trends in trial completion, reporting, and enrollment of racial and ethnic minority groups

The authors aimed to compare early-phase and late-phase clinical trials in gynecologic oncology regarding trial completion rates and the enrollment of racial and ethnic minority groups (REMGs). They found that early-phase trials had higher publication rates, while late-phase trials were more likely to report race/ethnicity data, although early-phase trials enrolled a greater proportion of REMGs. The study highlights the need for further investigation into the low publication rates and under-enrollment of REMGs in late-phase trials to address these disparities.